Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VEEV · against 1,336 other Healthcare companies
Ranked #716 of 1,337 · scores higher than 46% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 40–49, including VEEV · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | VEEV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 2.0% | 1.5% | 54% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 2.6% | 4.2% | 42% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 3.4% | -1.0% | 70% | 20% | |
| Book yieldHigher is better · 1,306 reported | 14.8% | 37.9% | 21% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 716 | 1.26T USD | 46 | 62 | |
| 716 | 532M USD | 46 | 34 | |
| 716 | 40.2B USD | 46 | 73 | |
| 716 | 11.4B USD | 46 | 64 | |
| 716 | 49.1B USD | 46 | 69 | |
| 730 | 5.4B CNY (≈$755M) | 45 | 54 | |
| 730 | 443.6B KRW (≈$319M) | 45 | 44 | |
| 730 | 3.1B CNY (≈$434M) | 45 | 35 | |
| 730 | 9.3B CNY (≈$1.3B) | 45 | 56 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score